Cargando…
Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III
The aim of the present study was to investigate epidermal growth factor receptor (EGFR) mutations as a prognostic factor for postoperative patients with positive EGFR mutations treated with postoperative platinum-based adjuvant chemotherapy (PBAC), and whether two common EGFR mutations exhibit diffe...
Autores principales: | Kawaguchi, Yohei, Okano, Tetsuya, Imai, Kentaro, Maehara, Sachio, Maeda, Junichi, Yoshida, Koichi, Hagiwara, Masaru, Kakihana, Masatoshi, Kajiwara, Naohiro, Ohira, Tatsuo, Matsubayashi, Jun, Ikeda, Norihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876293/ https://www.ncbi.nlm.nih.gov/pubmed/31807168 http://dx.doi.org/10.3892/ol.2019.11050 |
Ejemplares similares
-
Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
por: Shimada, Yoshihisa, et al.
Publicado: (2021) -
Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer
por: Ohira, Tatsuo, et al.
Publicado: (2016) -
Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers
por: Shimada, Yoshihisa, et al.
Publicado: (2020) -
Sublobar resection utilizing near-infrared thoracoscopy with intravenous indocyanine green for intralobar pulmonary sequestration: a case report and literature review
por: Kanno, Chiaki, et al.
Publicado: (2023) -
Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)